DOWDEN NATHAN J (Chief Operating Officer) sold 7.0% of their position (15K shares) of ENTRADA THERAPEUTICS, INC. on the open market
Open‑market sale worth $230.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/4/2026ACC: 0001873392-26-000004
Officer· Chief Operating Officer
Since Oct 2021
-15K
Net shares
Net seller
$230.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
15K acquired · 30K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+15K
Price / share
$1.74
Trade value
$26.10K
% of position
7.6%
5/4/2026
198.59K→213.59K
Common Stock
Direct
Shares
−15K
Price / share
$15.33
Trade value
$229.95K
% of position
7.0%
5/4/2026
213.59K→198.59K
Total
Net shares
+0.00
Net value
-$203.85K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/4/2026 | M · Option Exercise | +15K | $1.74 | $26.10K | 7.6% | 198.59K | 213.59K |
| Common Stock Direct | 5/4/2026 | S · Sale | −15K | $15.33 | $229.95K | 7.0% | 213.59K | 198.59K |
| Total | +0.00 | -$203.85K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
15K shares
Shares
−15K
Strike price
1.74
Held after
49.83K
Exercisable
—
5/4/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock15K shares | 5/4/2026 | M · Option Exercise | −15K | 1.74 | — | 49.83K |